<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 45-year-old woman with severe idiopathic marrow failure was prepared for marrow transplantation by administration of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (cy) 50 mg/kg on each of four successive days </plain></SENT>
<SENT sid="1" pm="."><plain>She then received an intravenous infusion of 20 X 10(9) nucleated marrow cells from an <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-A matched and mixed lymphocyte culture (MLC) non-reactive sister </plain></SENT>
<SENT sid="2" pm="."><plain>There was evidence for minimal marrow recovery in 1-2 months and a second marrow infusion was carried out 69 days after the first without additional immunosuppression </plain></SENT>
<SENT sid="3" pm="."><plain>There was a continued slow recovery of peripheral blood counts with complete reconstitution of erythropoiesis, return of the white blood cell count to between 3 and 4000/mm3, with 50% granulocytes, and platelets to 60--70,000/mm3, 11 months after the initial grafting attempt </plain></SENT>
<SENT sid="4" pm="."><plain>Red cell antigens and gamma globulin allotypes were of recipient type </plain></SENT>
<SENT sid="5" pm="."><plain>The MLC and the indirect cell mediated lympholysis (<z:mp ids='MP_0005481'>CML</z:mp>) test became positive possibly indicating cellular sensitization to non <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-A antigens </plain></SENT>
<SENT sid="6" pm="."><plain>This report of a patient with severe marrow failure documents autologous recovery of marrow function after receiving a large dose of cy and allogeneic marrow </plain></SENT>
<SENT sid="7" pm="."><plain>The implications of this are discussed </plain></SENT>
</text></document>